Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern. (2021)
Attributed to:
G2P-UK; A National Virology Consortium to address phenotypic consequences of SARSCoV-2 genomic variation
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41564-021-00974-0
PubMed Identifier: 34654917
Publication URI: http://europepmc.org/abstract/MED/34654917
Type: Journal Article/Review
Volume: 6
Parent Publication: Nature microbiology
Issue: 11
ISSN: 2058-5276